Gerd symptoms with tegoprazan treatment in adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multi-center, prospective observational study in adults with GERD who will be prescribed tegoprazan 50 mg in tablet or ODT form. Participants are observed to monitor safety and changes in symptoms over time without a mandated treatment protocol. Data will be collected from routine clinical care to describe real-world outcomes and tolerability. The study does not assign treatments but captures information from patients receiving tegoprazan as part of standard practice. It aims to provide practical insights into the safety profile and symptom improvement in a real-world setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Subjects over 19 years of age as of the date of consent
2. Subjects with a total score of 8 or more in the Korean Gastroesophageal Reflux Disease Questionnaire (GerdQ) based on Visit 1
3. Subjects who voluntarily decides to participate and agrees in writing to the consent form of the study

Exclusion Criteria:

1. Subjects who have hypersensitivity reactions and a medical history of Benzimidazole or components of the investigational drug
2. Subjects on Atazanavir, Nelfinavir, or Rilpivirine-containing medications
3. Pregnant and lactating women

Where it's running

• HK inno.N
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: yong an jeong
• Email: yongan.jeong@inno-n.com
• Phone: 82-31-5176-4673

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quality sleep improvement with evening topical therapy for nocturnal GERD

  This trial tests a medical device given before bed to see if it reduces nighttime GERD symptoms and improves sleep and quality of life in adults with nocturnal reflux.

  Recruiting Cellmedis · Warsaw, Masovian Voivodeship and 1 other locations · NCT07700342

• New topical treatment options for GERD symptoms

  This trial tests a medical device to see if it relieves GERD symptoms and improves quality of life in adults compared with a placebo.

  Recruiting Cellmedis · Warsaw, Masovian Voivodeship · NCT07624383

• Left-sided versus traditional bilateral laparoscopic repair for hiatal hernia with reflux

  This compares two laparoscopic operations—a left-sided approach and the traditional bilateral approach—to see which helps adults (18–85) with hiatal hernia whose reflux doesn't get better on usual acid‑reducing medicine.

  Recruiting Beijing Friendship Hospital · Beijing and 1 other locations · NCT07252115

• Improving GERD medication adherence using the GERDCare smartphone app

  This project will test whether the GERDCare smartphone app helps adults with GERD stick to their medications, diet, and lifestyle changes over four weeks.

  Recruiting Institute of Gastroenterology and Hepatology, Vietnam · Hanoi · NCT07125521

• How three ice-cream formulations affect esophageal movement in people with GERD or weak esophageal motility

  This test will try three specially made ice creams to see if they change how the esophagus moves in people with ineffective esophageal motility or GERD.

  Recruiting Federal State Budgetary Scientific Institution · Moscow · NCT07121803

• Normal 24-hour esophageal pH‑impedance values in healthy Indian adults

  This project will measure 24-hour esophageal pH‑impedance readings, including acid exposure time, in healthy Indian adults to see what normal values are.

  Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telangana · NCT06928350

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.